Hepatoblastoma: 15-year experience and role of surgical treatment

Journal of the Korean Surgical Society

Volumn 81, Issue 2, 2011, Pages 134-140

  Moon, Suk Bae ^a   Shin, Hyun Baek ^a   Seo, Jeong Meen ^a   Lee, Suk Koo ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Drug therapy; Hepatoblastoma; Surgery; Transplantation

Indexed keywords

EID: 80051879921     PISSN: 12260053     EISSN: 20930488     Source Type: Journal    
DOI: 10.4174/jkss.2011.81.2.134     Document Type: Review

References (17)

1. Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, et al. Pretreatment prognostic factors for children with hepatoblastoma: Results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000;36:1418-25. (Pubitemid 30421147)
2. Douglass EC, Reynolds M, Finegold M, Cantor AB, Glicksman A. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: A Pediatric Oncology Group study. J Clin Oncol 1993;11:96-9. (Pubitemid 23059981)
3. Atkinson JB, DeUgarte DA. Liver tumors. In: Grosfeld JL, O'Neill JA, Fonkalsrud EW, Coran AG, editors. Pediatric surgery. 6th ed. Philadelphia: Mosby; 2006. p.502-14.
4. Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, et al. Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004;42:74-83. (Pubitemid 38173460)
5. Pritchard J, Brown J, Shafford E, Perilongo G, Brock P, Dicks-Mireaux C, et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: A successful approach: Results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 2000;18:3819-28.
6. Aronson DC, Schnater JM, Staalman CR, Weverling GJ, Plaschkes J, Perilongo G, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: Results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 2005;23:1245-52. (Pubitemid 46202282)
7. Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: Final results of the SIOPEL- 3HR study. J Clin Oncol 2010;28:2584-90.
8. Sasaki F, Matsunaga T, Iwafuchi M, Hayashi Y, Ohkawa H, Ohira M, et al. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg 2002;37: 851-6. (Pubitemid 34575792)
9. Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, et al. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen: A report from the study group for pediatric solid malignant tumors in the Kyushu area. J Pediatr Surg 2004;39:195-8. (Pubitemid 38146436)
10. Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: A report from the Children's Oncology Group. Pediatr Blood Cancer 2009;53:1016-22.
11. Otte JB. Progress in the surgical treatment of malignant liver tumors in children. Cancer Treat Rev 2010;36:360-71.
12. Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, et al. Survival after liver transplantation for hepatoblastoma: A 2-center experience. J Pediatr Surg 2008;43: 1973-81.
13. Cillo U, Ciarleglio FA, Bassanello M, Brolese A, Vitale A, Boccagni P, et al. Liver transplantation for the management of hepatoblastoma. Transplant Proc 2003;35:2983-5. (Pubitemid 38102108)
14. Srinivasan P, McCall J, Pritchard J, Dhawan A, Baker A, Vergani GM, et al. Orthotopic liver transplantation for unresectable hepatoblastoma. Transplantation 2002;74:652-5.
15. Aretz S, Koch A, Uhlhaas S, Friedl W, Propping P, von Schweinitz D, et al. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 2006;47:811-8. (Pubitemid 44476759)
16. Phillips M, Dicks-Mireaux C, Kingston J, Malone M, Mitchell C, Pritchard J, et al. Hepatoblastoma and polyposis coli (familial adenomatous polyposis). Med Pediatr Oncol 1989;17:441-7. (Pubitemid 19248199)
17. Thomas D, Pritchard J, Davidson R, McKiernan P, Grundy RG, de Ville de Goyet J. Familial hepatoblastoma and APC gene mutations: Renewed call for molecular research. Eur J Cancer 2003;39:2200-4 (Pubitemid 37297746)